We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sidelines Alexza’s Adasuve NDA Over Manufacturing Shortfall
FDA Sidelines Alexza’s Adasuve NDA Over Manufacturing Shortfall
June 4, 2012
The FDA will not approve Alexza Pharmaceuticals’ drug-device combination product for agitation drug Adasuve until the company clears up manufacturing lapses outlined in a complete response letter (CRL).